This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Ebola: Health insurers stay calm but alert

Nimmagadda also says that Cigna is closely monitoring the situation in Dallas and “will work with public health professionals, customers, clients, and local health care professionals as necessary.”

Aetna, too, is monitoring the situation closely but agrees with the CDC, which has said that even with the latest developments, Ebola poses no significant threat to the general population in the U.S.,  says spokeswoman Cynthia Michener.

Duncan has been given brincidofovir, an anti-viral drug that has shown promise in the laboratory but had not yet been tested in humans. The manufacturer of the drug, Chimerix, received special permission from the Food and Drug Administration to provide it to him.   

Generally, health insurance companies don't cover the cost of “experimental” treatments. Michener says Aetna would “continue to follow the guidance of health authorities closely on any treatment options they determine are viable.” Currently, she notes, the treatment given Duncan “is still in trials, unproven in humans, and not yet approved by the FDA.”

In fact, "experimental" is one of 12 words never to say to your insurance company.

Manufacturers generally cover the cost of such ad-hoc treatments that have not yet gone through FDA trials and approval. So health insurance companies would not be on the hook for what could be costly medications.

Health insurance companies help keep everyone informed

While an Ebola outbreak is not likely here, Nimmagadda says, Cigna, like all health insurance companies, takes any possibility of an outbreak seriously and works with its providers and patients to keep them informed about unusual health threats.

Health insurance companies, including Cigna and Aetna, also are taking steps to raise awareness of Ebola among their customers, clients, health care professionals and employees.

Cigna continually educates its health care providers and members about what they can do to prevent the spread of infectious diseases, whether it's the flu, whooping cough or other viruses and infections. For example, Nimmagadda says, "We remind them of the need to wash their hands and to avoid coming in contact with bodily fluids from infected patients," she says. In today's health care settings in the U.S., she says, "you can isolate any contagious [patients] pretty effectively and you take precautions even if you didn't know what it is they might have."

2 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $94.31 0.72%
FB $117.86 -0.60%
GOOG $694.49 -0.53%
YHOO $35.97 -1.50%
TSLA $234.30 -3.10%


Chart of I:DJI
DOW 17,685.64 -205.52 -1.15%
S&P 500 2,058.40 -23.03 -1.11%
NASDAQ 4,758.1620 -59.4320 -1.23%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs